CDH2 and prostate carcinoma: Since we have previously shown that N-cadherin is the most representative marker for epithelial-mesenchymal transition in clinical prostate cancer, these findings indicate that the HGF/MET pathway plays a minor role in early hormone-naive prostate cancer [28].